AR053098A1 - Analgesico derivado de morfinano - Google Patents

Analgesico derivado de morfinano

Info

Publication number
AR053098A1
AR053098A1 ARP050104603A ARP050104603A AR053098A1 AR 053098 A1 AR053098 A1 AR 053098A1 AR P050104603 A ARP050104603 A AR P050104603A AR P050104603 A ARP050104603 A AR P050104603A AR 053098 A1 AR053098 A1 AR 053098A1
Authority
AR
Argentina
Prior art keywords
alkyl
atoms
atom
nr8r9
represent
Prior art date
Application number
ARP050104603A
Other languages
English (en)
Spanish (es)
Inventor
N Tzumimoto
K Kawamura
T Komagata
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of AR053098A1 publication Critical patent/AR053098A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP050104603A 2004-11-04 2005-11-03 Analgesico derivado de morfinano AR053098A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004320583 2004-11-04

Publications (1)

Publication Number Publication Date
AR053098A1 true AR053098A1 (es) 2007-04-25

Family

ID=36319248

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104603A AR053098A1 (es) 2004-11-04 2005-11-03 Analgesico derivado de morfinano

Country Status (12)

Country Link
US (1) US8470845B2 (cg-RX-API-DMAC7.html)
EP (1) EP1820505A4 (cg-RX-API-DMAC7.html)
JP (1) JP4706636B2 (cg-RX-API-DMAC7.html)
KR (1) KR101285645B1 (cg-RX-API-DMAC7.html)
CN (1) CN101090722B (cg-RX-API-DMAC7.html)
AR (1) AR053098A1 (cg-RX-API-DMAC7.html)
CA (1) CA2586181C (cg-RX-API-DMAC7.html)
MX (1) MX2007005336A (cg-RX-API-DMAC7.html)
NO (1) NO20072832L (cg-RX-API-DMAC7.html)
PE (1) PE20060723A1 (cg-RX-API-DMAC7.html)
TW (1) TW200621785A (cg-RX-API-DMAC7.html)
WO (1) WO2006049248A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5119925B2 (ja) 2005-11-09 2013-01-16 東レ株式会社 機能性腸障害の治療または予防剤
CA2634055C (en) * 2005-12-21 2011-07-05 Toray Industries, Inc. Antitussive agent
FR2902341B1 (fr) 2006-06-16 2011-02-25 Scras Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
FR2910327B1 (fr) 2006-12-22 2013-04-26 Scras Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
KR101546398B1 (ko) * 2007-05-21 2015-08-26 도레이 카부시키가이샤 결정성 미분화 입자
KR101510799B1 (ko) * 2007-05-21 2015-04-10 도레이 카부시키가이샤 의약 정제의 제조법
CN101848713B (zh) * 2007-05-21 2012-04-11 东丽株式会社 含有特定的有机酸的口服制剂以及口服制剂的溶出性和化学稳定性的改善方法
FR2930447B1 (fr) 2008-04-25 2010-07-30 Sod Conseils Rech Applic Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique
HUE069820T2 (hu) 2018-03-08 2025-04-28 Victoria Link Ltd Nalfurafin alkalmazása demielinizációs betegségek kezelésére

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118823B1 (cg-RX-API-DMAC7.html) * 1964-02-03 1966-10-31
US3318886A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 7-hydroxymethyl-7, 8-dihydro-6-amino-6, 14-endoethenocodides and morphide
NL8102558A (nl) * 1981-05-25 1982-12-16 Alcoa Nederland Bv Lichtmast met versterking van de opening in het onderste gedeelte.
JP2525552B2 (ja) * 1992-01-23 1996-08-21 東レ株式会社 モルヒナン誘導体および医薬用途
DE69424853T2 (de) 1993-07-23 2000-10-05 Toray Industries, Inc. Morphinan-derivate und ihre medizinische verwendung
ATE259232T1 (de) 1995-03-03 2004-02-15 Endo Pharmaceuticals Inc Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz
CN1374963A (zh) 1999-07-19 2002-10-16 东丽株式会社 尿频或尿失禁的治疗或预防剂
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
DE60133584T2 (de) * 2000-10-31 2009-06-04 Rensselaer Polytechnic Institute 4-arylpiperidine als opioidrezeptorbindende agenzien
EP1555266B1 (en) 2002-10-09 2014-05-21 Toray Industries, Inc. Remedies or preventives for urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group
JP4118824B2 (ja) 2004-02-24 2008-07-16 株式会社日立製作所 優先パケットの遅延を最小化するシェーピング装置
JP4118826B2 (ja) 2004-03-01 2008-07-16 リオン株式会社 補聴器用ケースなどの製造方法及びその装置
US7718664B2 (en) 2004-03-30 2010-05-18 Toray Industries, Inc. Anti-itching agent

Also Published As

Publication number Publication date
US20070299100A1 (en) 2007-12-27
TWI356826B (cg-RX-API-DMAC7.html) 2012-01-21
JP4706636B2 (ja) 2011-06-22
WO2006049248A1 (ja) 2006-05-11
US8470845B2 (en) 2013-06-25
CA2586181C (en) 2012-11-27
MX2007005336A (es) 2007-06-25
EP1820505A1 (en) 2007-08-22
EP1820505A4 (en) 2010-01-20
JPWO2006049248A1 (ja) 2008-08-07
CN101090722A (zh) 2007-12-19
KR20070085436A (ko) 2007-08-27
HK1115808A1 (en) 2008-12-12
TW200621785A (en) 2006-07-01
CA2586181A1 (en) 2006-05-11
PE20060723A1 (es) 2006-08-29
CN101090722B (zh) 2011-12-21
NO20072832L (no) 2007-08-01
KR101285645B1 (ko) 2013-07-12

Similar Documents

Publication Publication Date Title
AR091790A1 (es) Derivados de isoquinolin-1-ona y sus usos
CO6251241A2 (es) Compuestos de prolina modificados con actividad anti-vhc
AR053098A1 (es) Analgesico derivado de morfinano
AR030324A1 (es) Derivados de 4-fenil-piridina
AR047163A1 (es) Derivados de ciclohexano espirociclicos con afinidad por el receptor orl1
AR031528A1 (es) Compuestos de pirazolopirimidina y su uso para preparar una composicion farmaceutica
AR038863A1 (es) Uso de un inhibidor de garft y/o de aicarft y de un agente antitoxico para preparar un medicamento para destruir selectivamente celulas mtap-deficientes de un mamifero
AR062677A1 (es) Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden
AR077267A1 (es) Derivados nitrogenados heterociclicos inhibidores selectivos de pi3k, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades inflamatorias y/o autoinmunes.
EA200600527A1 (ru) Активирующее ppar соединение и содержащая его фармацевтическая композиция
AR063331A1 (es) Derivados de biaril eter urea y composiciones farmaceuticas
AR088218A1 (es) Compuestos heterociclicos utiles como inhibidores de pi3k
AR045651A1 (es) Derivados de tiazol como moduladores del receptor de cannabinoide
CR20200540A (es) DERIVADOS DE AMINA PARA EL CONTROL DE PLAGAS (Divisional 2019-0244)
AR064287A1 (es) Inhibidores de aspartil protesa
AR077328A1 (es) Derivados de oxazina y su uso en el tratamiento de trastornos neurologicos
AR050434A1 (es) Derivados de ciclohexano como inhibidores de cotransportador de na+ - glucosa; composiciones farmaceuticas que los contienen como principio activo y el uso de los mismos en el tratamiento de la diabates tipo i y ii y de la obesidad
AR086156A1 (es) Compuesto de amida y su uso medicinal
AR063988A1 (es) Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR082889A1 (es) Compuestos y composiciones para la inhibicion de nampt
AR084905A1 (es) Derivados de 2,3-dihidro-furo[2,3-c]piridina, composiciones farmaceuticas que los comprenden y su uso en el tratamiento de enfermedades mediadas por la activacion del receptor gpr119 acoplado a proteinas g
AR075249A1 (es) Derivados de 6-(6-o-sustituido-triazolopiridazina-sulfanil) benzotiazoles y bencimidazoles, metodo de preparacion de los mismos e intermediarios de dicha sintesis, medicamentos que los contienen y uso de los mismos en el tratamiento del cancer, artritis, alergias y otras enfermedades.
ECSP067053A (es) 1-aza-biciclo[3.3.1]nonanos
AR066604A1 (es) Derivados de arilamida pirimidona, medicamentos que los contienen y usos terapeuticos para prevenir y/o tratar enfermedades neurodegenerativas fundamentalmente.
AR076615A1 (es) Metodo para producir microcapsulas

Legal Events

Date Code Title Description
FA Abandonment or withdrawal